~~<i id='9FD07596F0'><strike id='9FD07596F0'><tt id='9FD07596F0'><pre id='9FD07596F0'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

author：fashion 2025-09-06 02:06:40 - browse：651

A box of Sudafed PE sinus pressure and pain medicine. -- health coverage from stat — PATRICK T. FALLON/AFP via Getty Images

You would have been forgiven for being surprised on Sept. 12 when a panel of advisers to the Food and Drug Administration concluded that the active ingredient in Sudafed PE and other over-the-counter decongestants is completely ineffective. It was front-page news, birthed myriad explainer stories on the internet, and even inspired a lawsuit against companies that sold the medicine, phenylephrine.

Yet when T.J. Parker, the entrepreneur and pharmacist who sold PillPack to Amazon, saw the news, he tweeted, “Didn’t everyone know this?”

He had a point.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： ASCO Daily Recap: CAR

entertainment

knowledge

explore

focus

hotspot

UnitedHealthGroupCEOAndrewWittysaidthecompanywasbeginningtoseea“disturbance”initsMedicaidmedicalcost

WSS

BD to buy Edwards patient monitoring unit for $4.2 billion

Ransomware attacks on hospitals: Study outlines patient impact

Weight loss drug costs may need more research, senator suggests

Eli Lilly’s Zepbound improved liver scarring in mid

FTC loses bid to block Novant's North Carolina hospital merger

World's first CRISPR

Wikipedia

Wikipedia

entertainment

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

In key trial, Verve's treatment lowers cholesterol levels in patients

Supreme Court strikes down use of affirmative action

Eli Lilly’s Zepbound improved liver scarring in mid

Trump demands the U.S. pay no more for drugs than other countries … again

Childhood cancer progress stalls for Black, Hispanic kids: Report

BioMarin wins approval for gene therapy to treat hemophilia A

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Structure Therapeutics oral GLP

knowledge

World's first CRISPR

Poor hospice wound care hurts patients and families

Gain of function research would be limited under House proposal

UnitedHealth CEO's Medicaid comments send insurer stocks diving

Childhood cancer progress stalls for Black, Hispanic kids: Report

Structure Therapeutics oral GLP

explore

focus

hotspot

hotspot